
Opinion|Videos|October 16, 2024
Patient Education and Emerging Therapies
Key Takeaways
- Clear communication and personalized care plans enhance patient understanding and adherence to treatment for type 2 inflammatory conditions.
- Utilizing tailored educational resources ensures patients comprehend their condition and the importance of adhering to treatment plans.
Panelists discuss how health care providers can improve patient education and support for type 2 inflammatory conditions through personalized communication strategies and shared decision-making, while also evaluating the role of emerging biologic therapies in treatment plans based on individual patient factors, disease severity, and biomarker profiles.
Advertisement
Episodes in this series

- How can health care providers better educate and support patients in understanding type 2 inflammatory conditions and adhering to treatment plans?
- What are your perspectives on the emerging biologic therapies targeting type 2 inflammation? How do you determine when these treatments may be appropriate for your patients?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
5 Expanded FDA Approvals From October
3
Missed Hepatitis B Treatment Opportunities in the US Increase Health Risks
4
Trial Data Yield Risk-Based NRSTS Treatment Strategies
5
















































